| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer
|
Sato, Yasushi
|
|
2015
|
75 |
3 |
p. 587-594
|
artikel
|
| 2 |
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma
|
D’ Angelo, Sandra P.
|
|
2015
|
75 |
3 |
p. 629-638
|
artikel
|
| 3 |
A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
|
Soejima, Kenzo
|
|
2015
|
75 |
3 |
p. 513-519
|
artikel
|
| 4 |
A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer
|
Choi, Dae Ro
|
|
2015
|
75 |
3 |
p. 639-643
|
artikel
|
| 5 |
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
|
Newman, Edward M.
|
|
2015
|
75 |
3 |
p. 537-546
|
artikel
|
| 6 |
A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
|
Yamazaki, Kentaro
|
|
2015
|
75 |
3 |
p. 569-577
|
artikel
|
| 7 |
Autophagy modulation: a target for cancer treatment development
|
Duffy, Alison
|
|
2014
|
75 |
3 |
p. 439-447
|
artikel
|
| 8 |
Dosing algorithm revisit for busulfan following IV infusion
|
Wang, Yanlin
|
|
2015
|
75 |
3 |
p. 505-512
|
artikel
|
| 9 |
Effect of axitinib on the QT interval in healthy volunteers
|
Ruiz-Garcia, Ana
|
|
2015
|
75 |
3 |
p. 619-628
|
artikel
|
| 10 |
Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
|
Kenmotsu, Hirotsugu
|
|
2015
|
75 |
3 |
p. 521-526
|
artikel
|
| 11 |
Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial
|
Chen, Zhiyu
|
|
2015
|
75 |
3 |
p. 547-557
|
artikel
|
| 12 |
Erratum to: Does saturable formation of gemcitabine triphosphate occur in patients?
|
Tham, Lai-San
|
|
2015
|
75 |
3 |
p. 657
|
artikel
|
| 13 |
Intermittent dosing of aromatase inhibitors (AI) to improve tolerance in postmenopausal women: a rationale for future clinical studies
|
Salmon, R.
|
|
2015
|
75 |
3 |
p. 653-655
|
artikel
|
| 14 |
Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer
|
Liu, Ying
|
|
2015
|
75 |
3 |
p. 645-651
|
artikel
|
| 15 |
Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus
|
Géresi, Krisztina
|
|
2015
|
75 |
3 |
p. 609-618
|
artikel
|
| 16 |
Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma
|
Joshi, Shweta
|
|
2015
|
75 |
3 |
p. 595-608
|
artikel
|
| 17 |
Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo
|
Liu, Yaping
|
|
2014
|
75 |
3 |
p. 465-474
|
artikel
|
| 18 |
Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
|
Miyazaki, Tatsuya
|
|
2014
|
75 |
3 |
p. 449-455
|
artikel
|
| 19 |
Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
|
Han, Ji-Youn
|
|
2014
|
75 |
3 |
p. 475-483
|
artikel
|
| 20 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, T. C.
|
|
2015
|
75 |
3 |
p. 579-586
|
artikel
|
| 21 |
Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing
|
Nikanjam, Mina
|
|
2015
|
75 |
3 |
p. 495-503
|
artikel
|
| 22 |
Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice
|
Justino, Priscilla F. C.
|
|
2015
|
75 |
3 |
p. 559-567
|
artikel
|
| 23 |
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival
|
Kasuga, Akiyoshi
|
|
2014
|
75 |
3 |
p. 457-464
|
artikel
|
| 24 |
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study
|
Merchan, Jaime R.
|
|
2015
|
75 |
3 |
p. 485-493
|
artikel
|
| 25 |
The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer
|
Kaku, Yoshiko
|
|
2015
|
75 |
3 |
p. 527-535
|
artikel
|
Tijdschrift beschrijving